T Acute Lymphoblastic Leukemia — Trials

T Acute Lymphoblastic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

117 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 47
Recruiting: 28
Ph III recruiting: 2
Growth YoY: —
Industry share: 9%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 52.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (22)

clinicaltrialsPublishedShowing 1–7 of 7 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05596266	CD5 CAR-T Therapy for Refractory/Relapsed CD5+ T-cell Acute Lymphoblastic Leukemia	unknown	Phase 1	20	Xuanwu Hospital, BeijingOTHER	1	Oct 27, 2022	clinicaltrials
NCT05398614	SENL101 Autologous T Cell Injection in Adults With Relapsed or Refractory CD7+ Hematolymphoid Malignancies	unknown	Phase 1	18	Hebei Senlang Biotechnology Inc., Ltd.INDUSTRY	1	Jun 1, 2022	clinicaltrials